Intelligent Bio Solutions(INBS)
$1.50-0.26 (-14.77%)
INBS
Intelligent Bio Solutions financials statements
$1.50
At close:-0.26 (-14.77%)
Want to see INBS full AI Analyst Report?
Intelligent Bio Solutions (INBS) Ratios
336 Followers
Intelligent Bio Solutions Ratios
INBS's free cash flow for Q1 2027 was $-2.75M. For the 2027 fiscal year, INBS's free cash flow was increased by $0.00 and operating cash flow was $-2.75M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.44 | 0.77 | 1.57 | 0.66 | 2.33 |
| Quick Ratio | 1.35 | 0.65 | 1.42 | 0.49 | 2.33 |
| Cash Ratio | 0.81 | 0.19 | 1.16 | 0.26 | 1.77 |
| Solvency Ratio | -1.69 | -1.72 | -1.64 | -1.45 | -1.43 |
| Operating Cash Flow Ratio | -2.42 | -1.81 | -1.76 | -1.25 | -0.72 |
| Short-Term Operating Cash Flow Coverage | -81.13 | -49.09 | -12.11 | -12.79 | 0.00 |
| Net Current Asset Value | $ 446.23K | $ -1.30M | $ 2.94M | $ -2.81M | $ 5.06M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.03 | 0.08 | 0.18 | 0.00 |
| Debt-to-Equity Ratio | 0.33 | 0.09 | 0.14 | 0.50 | 0.00 |
| Debt-to-Capital Ratio | 0.25 | 0.09 | 0.12 | 0.34 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.23 | 0.00 | 0.00 | 0.17 | 0.00 |
| Financial Leverage Ratio | 2.17 | 2.75 | 1.65 | 2.73 | 1.86 |
| Debt Service Coverage Ratio | -71.60 | -35.70 | -9.72 | -11.84 | -1104.45 |
| Interest Coverage Ratio | -1174.37 | -174.82 | -61.52 | -56.35 | -1105.83 |
| Debt to Market Cap | 0.54 | 0.02 | 0.14 | 0.02 | 0.00 |
| Interest Debt Per Share | 1.24 | 0.65 | 4.12 | 10.65 | 0.10 |
| Net Debt to EBITDA | 0.19 | 0.08 | 0.55 | -0.04 | 0.99 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.63% | 40.85% | 45.81% | 25.99% | 0.00% |
| EBIT Margin | -295.55% | -341.50% | -330.46% | -830.71% | 0.00% |
| EBITDA Margin | -267.94% | -301.74% | -299.15% | -753.80% | 0.00% |
| Operating Profit Margin | -299.11% | -348.71% | -330.46% | -1002.11% | 0.00% |
| Pretax Profit Margin | -295.80% | -347.41% | -327.50% | -848.50% | 0.00% |
| Net Profit Margin | -294.91% | -346.23% | -326.40% | -845.89% | 0.00% |
| Continuous Operations Profit Margin | -295.80% | -347.41% | -327.50% | -848.50% | 0.00% |
| Net Income Per EBT | 99.70% | 99.66% | 99.66% | 99.69% | 99.66% |
| EBT Per EBIT | 98.89% | 99.63% | 99.10% | 84.67% | 99.97% |
| Return on Assets (ROA) | -104.10% | -128.11% | -73.71% | -102.68% | -67.24% |
| Return on Equity (ROE) | -225.57% | -352.75% | -121.94% | -279.86% | -125.38% |
| Return on Capital Employed (ROCE) | -179.78% | -367.21% | -123.48% | -281.71% | -108.42% |
| Return on Invested Capital (ROIC) | -176.09% | -334.68% | -109.48% | -238.95% | -108.42% |
| Return on Tangible Assets | -135.97% | -237.00% | -107.97% | -208.50% | -67.24% |
| Earnings Yield | -366.99% | -116.52% | -174.26% | -15.86% | -7.13% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.97 | 1.91 | 3.18 | 1.51 | 0.00 |
| Payables Turnover | 3.04 | 2.01 | 2.80 | 0.78 | 0.00 |
| Inventory Turnover | 5.17 | 2.84 | 2.17 | 0.95 | 0.00 |
| Fixed Asset Turnover | 2.06 | 9.51 | 3.57 | 1.02 | 0.00 |
| Asset Turnover | 0.35 | 0.37 | 0.23 | 0.12 | 0.00 |
| Working Capital Turnover Ratio | 8.82 | 3.26 | 5.86 | 0.60 | 0.00 |
| Cash Conversion Cycle | 23.93 | 138.24 | 152.68 | 157.07 | 0.00 |
| Days of Sales Outstanding | 73.47 | 191.21 | 114.76 | 241.95 | 0.00 |
| Days of Inventory Outstanding | 70.56 | 128.40 | 168.31 | 384.50 | 0.00 |
| Days of Payables Outstanding | 120.10 | 181.37 | 130.39 | 469.38 | 0.00 |
| Operating Cycle | 144.03 | 319.61 | 283.07 | 626.46 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -8.10 | -18.35 | -30.05 | -36.72 | -45.80 |
| Free Cash Flow Per Share | -8.18 | -18.79 | -30.75 | -39.24 | -50.98 |
| Dividend Paid and CapEx Coverage Ratio | -94.86 | -41.74 | -43.23 | -14.61 | -8.83 |
| Capital Expenditure Coverage Ratio | -94.86 | -41.74 | -43.23 | -14.61 | -8.83 |
| Operating Cash Flow Coverage Ratio | -6.56 | -34.34 | -8.35 | -3.85 | 0.00 |
| Operating Cash Flow to Sales Ratio | -2.83 | -3.17 | -3.08 | -5.87 | 0.00 |
| Free Cash Flow Yield | -355.83% | -109.24% | -168.02% | -11.76% | -3.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.27 | -0.86 | -0.57 | -6.31 | -14.03 |
| Price-to-Sales (P/S) Ratio | 0.80 | 2.97 | 1.87 | 53.34 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.61 | 3.03 | 0.70 | 17.65 | 17.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.28 | -0.92 | -0.60 | -8.50 | -31.18 |
| Price-to-Operating Cash Flow Ratio | -0.28 | -0.94 | -0.61 | -9.09 | -34.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.01 | 0.01 | 0.95 | 0.47 |
| Enterprise Value Multiple | -0.11 | -0.90 | -0.07 | -7.12 | -13.01 |
| Enterprise Value | 1.21M | 8.33M | 670.73K | 67.42M | 108.31M |
| EV to EBITDA | -0.11 | -0.90 | -0.07 | -7.12 | -13.01 |
| EV to Sales | 0.29 | 2.73 | 0.22 | 53.64 | 0.00 |
| EV to Free Cash Flow | -0.10 | -0.84 | -0.07 | -8.55 | -28.97 |
| EV to Operating Cash Flow | -0.10 | -0.86 | -0.07 | -9.14 | -32.25 |
| Tangible Book Value Per Share | 1.69 | -1.85 | 11.97 | -7.81 | 89.27 |
| Shareholders’ Equity Per Share | 3.74 | 5.68 | 26.15 | 18.91 | 90.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 2.86 | 5.79 | 9.77 | 6.26 | 0.00 |
| Net Income Per Share | -8.44 | -20.04 | -31.89 | -52.92 | -113.28 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.02 | 0.99 | 1.02 | 1.00 |
| Research & Development to Revenue | 0.80 | 0.79 | 0.54 | 0.40 | 0.00 |
| SG&A to Revenue | 2.49 | 2.91 | 2.74 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.05 | 0.08 | 0.07 | 0.21 | 0.00 |
| Income Quality | 0.96 | 0.91 | 0.94 | 0.69 | 0.40 |
Currency in USD

